Gene therapy has been elevated in the DMD field due to the promise that this approach could “stably” correct DMD defects via restoring dystrophin throughout the body (Gregorevic et al., 2006; Chamberlain and Chamberlain, 2017). The gene discussed is DMD; the disease is Duchenne muscular dystrophy.